Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Increased
Reduced
Net increased
Funds Holding
3,892
Funds Holding Change
+390
Funds Holding Growth
+11%
Value
$1.23T
Holding in Top 10
1,222
Top 10 Change
+257
Top 10 Growth
+27%
Value Growth
+18%
New
498
Increased
1,894
Reduced
1,324
Closed
52
Capital Inflow
$61.1B
Capital Outflow
$23.7B
Net Capital Flow
+$37.5B
Capital Flow Change
+$39.3B
Calls
$15.3B
Puts
$19.4B
Net Calls
-$4.11B
Put/Call Ratio
1.27